Feb 7th 2023 - Mar 21st 2023
Company doubled in size and reduced cash burn with... See more
Company doubled in size and reduced cash burn with... See more
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$TGTX MOST CONVENIENT- 50% faster infusion SAFE... See more
$TGTX next few weeks will be a good buying opportu... See more
This is a low risk HIGH REWARD here.
Company doubled in size and reduced cash burn with no risk of dilution.
Company doubled in size and reduced cash burn with no risk of dilution.
Doubled in size and reduced cash burn with no risk of dilution.
Incredible risk reward.
$BBAI IM a dip player this great risk reward ..tons of shorts are looking at that 3.3 hold .
Risk to reward is incredible
$TGTX MOST CONVENIENT- 50% faster infusion SAFEST - Zero Breast Cancer Risk MOST AFFORDABLE - By far If TGTX was a Big Pharma Company, the medical press would be blowing it up with praise.
$TGTX next few weeks will be a good buying opportunity for "risk on" assets imo.
but the potential return is outsized compared to the risk.
No breast cancer risk.
low risk high reward for long game
They're looking at the risk to reward ratio and they're liking what they see.
This is big stuff, and literally zero risk now..
The risk to reward ratio on this stock is really good imho.
